4//SEC Filing
GENEREX BIOTECHNOLOGY CORP 4
Accession 0001144204-10-012508
CIK 0001059784operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:07 PM ET
Size
18.8 KB
Accession
0001144204-10-012508
Insider Transaction Report
Form 4
MCGEE BRIAN
Director
Transactions
- Disposition to Issuer
Common Stock Purchase Option (right to buy)
2009-10-20−70,000→ 0 totalExercise: $0.94Exp: 2009-10-26→ Common Stock (70,000 underlying) - Award
Common Stock Purchase Option (right to buy)
2009-10-20+35,714→ 35,714 totalExercise: $0.00Exp: 2014-10-26→ Common Stock (35,714 underlying) - Disposition to Issuer
Common Stock Purchase Option (right to buy)
2009-10-20−100,000→ 0 totalExercise: $0.56Exp: 2010-04-04→ Common Stock (100,000 underlying) - Award
Common Stock Purchase Option (right to buy)
2010-03-08+100,000→ 100,000 totalExercise: $0.64Exp: 2020-03-07→ Common Stock (100,000 underlying) - Award
Common Stock Purchase Option (right to buy)
2009-10-20+70,000→ 70,000 totalExercise: $0.94Exp: 2014-10-26→ Common Stock (70,000 underlying) - Disposition to Issuer
Common Stock Purchase Option (right to buy)
2009-10-20−35,714→ 0 totalExercise: $0.00Exp: 2010-04-04→ Common Stock (35,714 underlying) - Award
Common Stock Purchase Option (right to buy)
2009-10-20+100,000→ 100,000 totalExercise: $0.56Exp: 2014-10-26→ Common Stock (100,000 underlying)
Footnotes (5)
- [F1]Deemed cancellation of option in connection with deemed grant of replacement option.
- [F2]The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on October 26, 2004. The original terms of vesting were not amended.
- [F3]The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended.
- [F4]The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended.
- [F5]This option becomes exercisable in three installments, with the first installment (33,333 shares) exercisable as of the date of grant, the second installment (33,3333 shares) exercisable as of August 1, 2010 and the third installment (33,334 shares) exercisable as of August 1, 2011.
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001059784
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:07 PM ET
- Size
- 18.8 KB